Commonwealth Equity Services’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,784
| Closed | -$916K | – | 3307 |
|
|
2020
Q3 | $916K | Sell |
10,784
-7,116
| -40% | -$360K | ﹤0.01% | 1549 |
|
|
2020
Q2 | $634K | Sell |
17,900
-3,976
| -18% | -$116K | ﹤0.01% | 1723 |
|
|
2020
Q1 | $294K | Sell |
21,876
-4,306
| -16% | -$72.5K | ﹤0.01% | 2082 |
|
|
2019
Q4 | $554K | Buy |
26,182
+1,994
| +8% | +$35.2K | ﹤0.01% | 1840 |
|
|
2019
Q3 | $320K | Buy |
24,188
+248
| +1% | +$3.65K | ﹤0.01% | 2181 |
|
|
2019
Q2 | $332K | Sell |
23,940
-3,698
| -13% | -$55.6K | ﹤0.01% | 2123 |
|
|
2019
Q1 | $530K | Sell |
27,638
-334
| -1% | -$5.38K | ﹤0.01% | 1717 |
|
|
2018
Q4 | $399K | Sell |
27,972
-2,019
| -7% | -$40.1K | ﹤0.01% | 1801 |
|
|
2018
Q3 | $624K | Sell |
29,991
-1,081
| -3% | -$25.6K | ﹤0.01% | 1638 |
|
|
2018
Q2 | $735K | Sell |
31,072
-400
| -1% | -$8.04K | ﹤0.01% | 1481 |
|
|
2018
Q1 | $459K | Buy |
31,472
+400
| +1% | +$6.54K | ﹤0.01% | 1771 |
|
|
2017
Q4 | $502K | Buy |
31,072
+13,072
| +73% | +$154K | ﹤0.01% | 1699 |
|
|
2017
Q3 | $252K | Sell |
18,000
-1,500
| -8% | -$14.9K | ﹤0.01% | 2103 |
|
|
2017
Q2 | $172K | Sell |
19,500
-6,000
| -24% | -$42.1K | ﹤0.01% | 2282 |
|
|
2017
Q1 | $165K | Sell |
25,500
-3,995
| -14% | -$20.2K | ﹤0.01% | 2208 |
|
|
2016
Q4 | $108K | Sell |
29,495
-1,820
| -6% | -$5.38K | ﹤0.01% | 2182 |
|
|
2016
Q3 | $102K | Buy |
31,315
+1,000
| +3% | +$2.8K | ﹤0.01% | 2112 |
|
|
2016
Q2 | $70K | Hold |
30,315
| – | – | ﹤0.01% | 2142 |
|
|
2016
Q1 | $76K | Hold |
30,315
| – | – | ﹤0.01% | 2093 |
|
|
2015
Q4 | $93K | Hold |
30,315
| – | – | ﹤0.01% | 2036 |
|
|
2015
Q3 | $52K | Sell |
30,315
-800
| -3% | -$2.04K | ﹤0.01% | 2050 |
|
|
2015
Q2 | $126K | Hold |
31,115
| – | – | ﹤0.01% | 2046 |
|
|
2015
Q1 | $119K | Buy |
31,115
+1,000
| +3% | +$4.35K | ﹤0.01% | 2031 |
|
|
2014
Q4 | $145K | Hold |
30,115
| – | – | ﹤0.01% | 1928 |
|
|
2014
Q3 | $112K | Hold |
30,115
| – | – | ﹤0.01% | 1945 |
|
|
2014
Q2 | $110K | Hold |
30,115
| – | – | ﹤0.01% | 1930 |
|
|
2014
Q1 | $127K | Hold |
30,115
| – | – | ﹤0.01% | 1859 |
|
|
2013
Q4 | $139K | Buy |
30,115
+850
| +3% | +$3.79K | ﹤0.01% | 1788 |
|
|
2013
Q3 | $181K | Hold |
29,265
| – | – | ﹤0.01% | 1652 |
|
|
2013
Q2 | $159K | Buy |
+29,265
| New | +$96.1K | ﹤0.01% | 1624 |
|
Commonwealth Equity Services's IMMU Position: Q4 2020 in Review
Commonwealth Equity Services sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 10,784 shares — an estimated $916K sold.
Commonwealth Equity Services first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $916K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Commonwealth Equity Services reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Commonwealth Equity Services sold 10,784 Immunomedics Inc shares in Q4 2020, an estimated $916K.
- Commonwealth Equity Services first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Commonwealth Equity Services's Immunomedics Inc position peaked at $916K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Commonwealth Equity Services's 13F filing for Q4 2020, filed 11 Feb 2021.